The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives

被引:30
作者
Li, Yifan [1 ,2 ]
Lu, Lan [3 ]
Wu, Xu [1 ,2 ]
Li, Qianxiu [1 ]
Zhao, Yueshui [1 ,2 ]
Du, Fukuan [1 ,2 ]
Chen, Yu [1 ,2 ]
Shen, Jing [1 ,2 ]
Xiao, Zhangang [1 ,2 ]
Wu, Zhigui [1 ,2 ,4 ]
Hu, Wei [5 ]
Cho, Chi Hin [1 ,2 ]
Li, Mingxing [1 ,2 ]
机构
[1] Southwest Med Univ, Sch Pharm, Dept Pharmacol, Lab Mol Pharmacol, Luzhou 646000, Sichuan, Peoples R China
[2] South Sichuan Inst Translat Med, Luzhou 646000, Sichuan, Peoples R China
[3] Chengdu Univ, Sch Pharm, Sichuan Ind Inst Antibiot, Antibiot Res & Re Evaluat Key Lab Sichuan Prov, Chengdu 610106, Sichuan, Peoples R China
[4] Southwest Med Univ, Affiliated Hosp, Dept Pharm, Luzhou 646000, Sichuan, Peoples R China
[5] Southern Med Univ, Shenzhen Hosp, Dept Gastroenterol, Guangzhou 518000, Peoples R China
基金
中国国家自然科学基金;
关键词
long non-coding RNA; gastric cancer; drug resistance; helicobacter pylori; tumor microenvironment; PROMOTES CISPLATIN RESISTANCE; HELICOBACTER-PYLORI INFECTION; REGULATORY T-CELLS; CHEMOTHERAPY RESISTANCE; MULTIDRUG-RESISTANCE; SIGNALING PATHWAY; MEDIATED TRANSFER; FEEDBACK LOOP; PROLIFERATION; PROGRESSION;
D O I
10.7150/ijbs.61410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gastric cancer (GC) is one of the major public health concerns. Long non-coding RNAs (lncRNAs) have been increasingly demonstrated to possess a strong correlation with GC and play a critical role in GC occurrence, progression, metastasis and drug resistance. Many studies have shed light on the understanding of the underlying mechanisms of lncRNAs in GC. In this review, we summarized the updated research about lncRNAs in GC, focusing on their roles in Helicobacter pylori infection, GC metastasis, tumor microenvironment regulation, drug resistance and associated signaling pathways. LncRNAs may serve as novel biomarkers for diagnosis and prognosis of GC and potential therapeutic targets. The research gaps and future directions were also discussed.
引用
收藏
页码:2737 / 2755
页数:19
相关论文
共 146 条
[1]   Non-coding RNA networks in cancer [J].
Anastasiadou, Eleni ;
Jacob, Leni S. ;
Slack, Frank J. .
NATURE REVIEWS CANCER, 2018, 18 (01) :5-18
[2]   LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression [J].
Ba, Ming-chen ;
Ba, Zheng ;
Long, Hui ;
Cui, Shu-zhong ;
Gong, Yuan-feng ;
Yan, Zhao-fei ;
Lin, Kun-peng ;
Wu, Yin-bing ;
Tu, Yi-nuo .
CELL DEATH & DISEASE, 2020, 11 (01)
[3]  
Bachmann MF, 1999, J IMMUNOL, V163, P1128
[4]  
Bae Susan, 2018, Genes Cancer, V9, P87, DOI 10.18632/genesandcancer.172
[5]   Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway [J].
Bing, Wang ;
Guan Guoxin ;
Zhao, Danyi .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 125
[6]   RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway (Retracted article. See vol. 142, 2021) [J].
Cao, Bole ;
Liu, Cuixia ;
Yang, Guifeng .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 :185-193
[7]   STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy [J].
Chen, Jin-Fei ;
Wu, Peng ;
Xia, Rui ;
Yang, Jian ;
Huo, Xin-Ying ;
Gu, Dong-Ying ;
Tang, Cui-Ju ;
De, Wei ;
Yang, Fen .
MOLECULAR CANCER, 2018, 17
[8]   LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214 [J].
Chen, Ying ;
Du, Hui ;
Bao, Lewen ;
Liu, Wenxin .
CANCER BIOLOGY & MEDICINE, 2018, 15 (03) :238-250
[9]   mTOR Cross-Talk in Cancer and Potential for Combination Therapy [J].
Conciatori, Fabiana ;
Ciuffreda, Ludovica ;
Bazzichetto, Chiara ;
Falcone, Italia ;
Pilotto, Sara ;
Bria, Emilio ;
Cognetti, Francesco ;
Milella, Michele .
CANCERS, 2018, 10 (01)
[10]   LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway [J].
Dai, Qingqiang ;
Zhang, Tianqi ;
Pang, Jiaomeng ;
Li, Chen .
JOURNAL OF CANCER, 2020, 11 (13) :3882-3892